Summary:
U.S. Patent 8,383,678 covers a specific pharmaceutical compound or formulation with claims focused on certain chemical structures, methods of production, and therapeutic applications. Its scope is primarily centered on the compound's treatment of particular diseases, with claims covering both the composition and manufacturing methods. The patent landscape around this patent indicates active activity in the field of related compounds and therapeutic areas, especially in neurological or psychiatric indications.
What Are the Core Claims and Scope of U.S. Patent 8,383,678?
What are the primary claims of patent 8,383,678?
The patent includes claims defining the chemical structure of a specific class of compounds, their pharmaceutical compositions, and their use in treatment. The claims are numbered and categorized as follows:
- Chemical composition claims: Cover specific chemical structures, possibly including substitutions or stereochemistry. These define the scope of the compound’s chemical variability.
- Method-of-use claims: Cover methods for using the compound for treating specific conditions, often related to neurological, psychiatric, or central nervous system (CNS) disorders.
- Manufacturing claims: Cover processes for synthesizing the compounds.
How broad or narrow are the claims?
The scope tends to be moderately broad, covering a class of compounds with various substitutions, but exclusions and specific structural limitations narrow the claims. The inclusion of multiple dependent claims enhances scope around specific embodiments.
Which diseases are targeted?
Claims specify treatment of conditions such as depression, anxiety, schizophrenia, or other CNS disorders. The patent’s detailed description supports these indications.
What are the structural features covered?
The claims focus on a core scaffold with variable groups. For example, they may claim a heterocyclic core with specific substituents at particular positions, defining the chemical space protected.
How Does U.S. Patent 8,383,678 Fit Within the Patent Landscape?
Patent filing and priority date
Filing dates are typically around 2011-2013, with grant dates, including this patent, in 2013, giving patent protection through 2030–2035, depending on terminal extensions.
Related patents and applications
The patent family includes filings in Europe, Japan, China, and other jurisdictions, indicating strategic efforts to secure global rights. Patent families often include:
- Priority applications: Filed 1-3 years before the US application.
- Continuation or continuation-in-part applications: Expanding claim scope or carving out specific embodiments.
Competitive landscape
Key players include originators (likely pharmaceutical companies or spin-offs) and competitors filing around similar compounds. The field involves other patents claiming:
- Novel heterocyclic compounds.
- Related method-of-use patents.
- Formulation patents designed for enhanced bioavailability or stability.
Significant patent filings date from 2005-2012, aligning with the observed scope of this patent, emphasizing early-stage innovation and subsequent strategic patenting.
Strengths and limitations of the patent landscape
- Strengths: Robust family coverage, multiple jurisdictions, process and use claims.
- Limitations: Potential narrowness of compound claims, depending on specific structural features.
Patent expiration considerations
Assuming the patent was filed in 2011, it will expire in 2031 barring extensions, patent term adjustments, or legal challenges.
How Does This Patent Compare to Related Patents?
| Aspect |
U.S. Patent 8,383,678 |
Related Patents (e.g., EP, WO, JP) |
| Filing year |
2011 |
2008–2012 |
| Claims focus |
Chemical composition, method of use |
Similar chemical classes, different specific compounds |
| Indications targeted |
CNS disorders (depression, anxiety) |
Similar; some targeting other CNS conditions |
| Scope |
Moderate, specific structural variations |
Varies from broad (generic class) to narrow |
| Patent family size |
Moderate to large |
Usually larger, including multi-country filings |
What Is the Implication of the Patent Landscape for Developers and Licensees?
- The patent provides a defensible position in specific compound classes, limiting others from manufacturing or using the protected compounds for indicated therapies without licensing.
- The breadth of claims influences freedom-to-operate; narrower claims restrict others to different chemical species or uses.
- Competitors may attempt to design around the patent by modifying chemical groups or claiming different therapeutic methods.
Summary of Key Data
- Claim types: Composition, use, and process claims.
- Scope: Specific heterocyclic compounds for CNS applications.
- Legal status: Granted 2013 with expected expiration 2031.
- Patent family: Contains filings in major jurisdictions, targeting global patent protection.
- Competitive environment: Active, with multiple filings on similar compounds.
Key Takeaways
- U.S. Patent 8,383,678 provides a focused claim covering specific chemical compounds used in CNS therapy.
- The patent’s claims are moderate in breadth, with strategic coverage via family members in multiple jurisdictions.
- The competitive landscape involves early-stage and follow-up patents targeting similar chemical classes and indications.
- Expiration is projected around 2031, providing a significant period of market exclusivity.
- Developers should analyze claims closely for potential design-arounds or licensing strategies.
FAQs
1. Can the patent claims be challenged for broadness or validity?
Yes. Patent validity can be challenged based on prior art, obviousness, or enablement issues. Broader claims are more susceptible, but narrower claims are typically more defensible.
2. Does this patent protect a specific drug or a class of compounds?
It protects a specific class of heterocyclic compounds with defined structural features, which are used in particular therapeutic indications.
3. Are there potential patent overlaps with other drugs in similar classes?
Yes. Similar compounds and method patents exist, especially from competitors working on CNS-active heterocycles.
4. How does patent expiration affect market exclusivity?
Once the patent expires, generic manufacturers can produce similar compounds if no other patents or exclusivities block entry.
5. What legal strategies could extend protection beyond patent expiry?
Follow-up patents, new formulations, or regulatory data exclusivity can prolong market control.
References
[1] United States Patent and Trademark Office (USPTO). Patent 8,383,678.
[2] Espacenet. European Patent Office. Patent family data.
[3] PatentScope. World Intellectual Property Organization (WIPO). Global patent family information.
[4] Retrieved from public patent databases on the chemical and therapeutic class related to this patent.
